Prothena Corp Public (PRTA) Free Cash Flow (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Free Cash Flow of $28.9 million in Q1 2026, up 223.87% quarter-over-quarter from -$23.3 million in Q4 2025, and up 154.07% on a YoY basis from $11.4 million in Q1 2025.
Prothena Corp Public (PRTA) Free Cash Flow (2012 - 2026) Analysis & Trends
Prothena Corp Public's Free Cash Flow history runs 15 years deep, the most recent figure standing at $28.9 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 154.07% year-over-year to $28.9 million; the TTM figure through Mar 2026 stood at -$81.4 million (up 37.64% YoY), while the FY2025 annual figure was -$163.7 million, down 8.89% from the prior year.
- Free Cash Flow was $28.9 million for Q1 2026 at Prothena Corp Public, up from -$23.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $28.9 million in Q1 2026 to a low of -$73.2 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$31.2 million across 5 years, with a median of -$40.6 million in 2025.
- The sharpest annual moves came in 2023 and 2026: Free Cash Flow plunged 925.69% in 2023, then soared 154.07% in 2026.
- A 5-year view of Free Cash Flow shows it stood at -$5.1 million in 2022, then slumped by 925.69% to -$52.6 million in 2023, then rose by 9.07% to -$47.8 million in 2024, then soared by 51.25% to -$23.3 million in 2025, then soared by 223.87% to $28.9 million in 2026.
- The last three Free Cash Flow figures came in at $28.9 million (Q1 2026), -$23.3 million (Q4 2025), and -$40.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 28.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.88 Mn |
| Mar 31, 2026 | 28.88 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Dec 31, 2025 | -23.31 Mn |
| Sep 30, 2025 | -40.58 Mn |
| Sep 30, 2025 | -40.58 Mn |
| Jun 30, 2025 | -46.43 Mn |
| Jun 30, 2025 | -46.43 Mn |
| Mar 31, 2025 | -53.41 Mn |
| Mar 31, 2025 | -53.41 Mn |
| Dec 31, 2024 | -47.82 Mn |
| Dec 31, 2024 | -47.82 Mn |
| Sep 30, 2024 | -45.20 Mn |
| Sep 30, 2024 | -45.20 Mn |
| Jun 30, 2024 | 15.82 Mn |
| Jun 30, 2024 | 15.82 Mn |
| Mar 31, 2024 | -73.15 Mn |
| Mar 31, 2024 | -73.15 Mn |
| Dec 31, 2023 | -52.59 Mn |
| Dec 31, 2023 | -52.59 Mn |